Scripps Research Logo

News Release

TSRI Ranks No. 1 in Innovation Influence

Annual Nature Index supplement ranks research institutes on influence over scientific patents.

LA JOLLA, CA—August 10, 2017—The Scripps Research Institute (TSRI) is the most influential research institution in the world, according to the Nature Index 2017 Innovation supplement, which sheds light on the impact of academic research on innovation. The ranking, released today by the journal Nature, analyzes data about research quality and the broad influence it has on inventions.

“This new ranking underscores the worldwide impact of TSRI scientists, who share a common goal of improving public health through scientific discovery, and, importantly, improving the way we make those discoveries,” said Jamie Williamson, TSRI’s Executive Vice President for Research and Academic Affairs. “We are proud to be recognized for the profound influence our science has had on other researchers and laboratories around the world.”

The Normalized Lens Influence Metric used by the Nature Index measures the influence an institution’s research has had on innovation by calculating the citations of its research articles in patents owned by third parties, rather than those owned by institutions themselves.

According to this metric, TSRI ranks number one, above other internationally renowned research institutes such as the Rockefeller University in New York, the Massachusetts Institute of Technology and Stanford University.

“This analysis comes at a time when following the transfer of scientific knowledge into industry and the economy is a growing priority for governments and research funding agencies, said David Swinbanks, founder of the Nature Index. “For them, the need to demonstrate that publicly funded science is being used for society’s benefit is paramount,”

A key metric in this ranking is publications. More than 40 percent of all TSRI’s natural science articles appear in the Nature Index. The average across the 200 institutions listed is 21.9 percent.

TSRI scientists are also active in developing their own innovations, with more than 1,000 patents and seven FDA approved drugs to their credit. Additionally, the Institute’s recent alliance with the California Institute for Biomedical Research (Calibr) adds translational research to its capabilities, enabling a new bench-to-bedside model that will accelerate the translation of basic scientific discoveries into critically-needed new medicines for unmet medical needs.

About The Scripps Research Institute

The Scripps Research Institute (TSRI) is one of the world's largest independent, not-for-profit organizations focusing on research in the biomedical sciences. TSRI is internationally recognized for its contributions to science and health, including its role in laying the foundation for new treatments for cancer, rheumatoid arthritis, hemophilia, and other diseases. An institution that evolved from the Scripps Metabolic Clinic founded by philanthropist Ellen Browning Scripps in 1924, the institute now employs more than 2,500 people on its campuses in La Jolla, CA, and Jupiter, FL, where its renowned scientists—including two Nobel laureates and 20 members of the National Academies of Science, Engineering or Medicine—work toward their next discoveries. The institute's graduate program, which awards PhD degrees in biology and chemistry, ranks among the top ten of its kind in the nation. In October 2016, TSRI announced a strategic affiliation with the California Institute for Biomedical Research (Calibr), representing a renewed commitment to the discovery and development of new medicines to address unmet medical needs. For more information, see

# # #

For information:
Office of Communications
Tel: 858-784-2666
Fax: 858-784-8118